Sandler Laura Lee 4

What Happened

Laura Sandler, Chief Operating Officer of Oruka Therapeutics, sold 600 shares on 2026-06-15 at $69.69 per share for a total of $41,814. The filing lists the transaction as an open market or private sale (code S) and notes the sale was effected under the company’s automatic, non-discretionary sell-to-cover procedure to satisfy tax withholding obligations arising from restricted stock unit (RSU) vesting.

Key Details

• Transaction date: 2026-06-15
• Price per share: $69.69; total proceeds: $41,814
• Transaction type: Sale (S) reported as open market or private sale
• Footnote: Sale was a sell-to-cover under the company’s automatic, non-discretionary procedure for RSU tax withholding (F1)
• Filing/Report date: 2026-06-15 (filed timely; no late filing indicated)
• Shares owned after transaction: Not specified in the provided filing

Context

Sell-to-cover transactions are routine administrative sales that occur when vested RSUs trigger tax withholding; a portion of shares is sold to cover taxes while the remaining shares (if any) are retained. Such sales are administrative in nature and do not necessarily indicate a change in the insider’s view of the company.